Login / Signup

Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post-hoc Analysis of TEMPO 3:4.

Jogarao V S GobburuVijay D IvaturiXiaofeng WangSusan E ShoafPravin JadhavVicente E Torres
Published in: Kidney360 (2023)
This analysis supports a relationship between effects on Uosm and inhibition of disease progression by tolvaptan and high water intake alone. The findings further suggest that 24-hour Uosm measurement is superior to spot Uosm for assessing suppression of vasopressin activity by tolvaptan.
Keyphrases
  • polycystic kidney disease
  • acute heart failure
  • blood pressure
  • weight gain
  • atrial fibrillation
  • weight loss